T-cell immunoglobulin and mucin-domain containing-3 in malignant cancers

被引:2
|
作者
Xu, Yun [1 ]
Jiang, Xiping [1 ]
Huang, Yaqing [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Gynecol, 185 Juqian St, Changzhou 213003, Peoples R China
关键词
T-cell immunoglobulin and mucin-domain containing-3 (Tim-3); human cancer; anti-Tim-3; antibody; cancer immunotherapy; 3 GENE POLYMORPHISMS; TIM-3; EXPRESSION; UP-REGULATION; THERAPEUTIC TARGET; POOR-PROGNOSIS; MELANOMA-CELLS; PD-1; DYSFUNCTION; ACTIVATION; EXHAUSTION;
D O I
10.21037/tcr.2017.05.08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune checkpoints are one of the key factors comprising the extensive network of the human immune system. Immune checkpoints ensure T-cell homeostasis, activation and differentiation. The checkpoint T-cell immunoglobulin and mucin-domain containing-3 (Tim-3) plays an important role in immune system. Tim-3 is a member of TIM family and can negatively regulate T helper 1 (Th1) immunity. A literature search for Tim-3 was performed via PubMed. It is suggested that the overexpression of Tim-3 is correlated with poorer prognosis for multiple cancers. Co-expression of Tim-3 and other immune checkpoints has been revealed. Blockade of Tim-3 exerts antitumor function and may have synergistic activity being alone or combined with anti-PD-1 antibody or chemotherapy. Thus, Tim-3 is a promising target for cancer immunotherapy.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 50 条
  • [21] High resolution X-ray and NMR structural study of human T-cell immunoglobulin and mucin domain containing protein-3
    Gandhi, Amit K.
    Kim, Walter M.
    Sun, Zhen-Yu J.
    Huang, Yu-Hwa
    Bonsor, Daniel A.
    Sundberg, Eric J.
    Kondo, Yasuyuki
    Wagner, Gerhard
    Kuchroo, Vijay K.
    Petsko, Gregory
    Blumberg, Richard S.
    SCIENTIFIC REPORTS, 2018, 8
  • [22] The Role of T cell Immunoglobulin and Mucin Domain-3 in Immune Thrombocytopenia
    Zhang, X. -M.
    Shan, N. -N.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 79 (04) : 231 - 236
  • [23] Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barre syndrome
    Liang, Song-lan
    Wang, Wei-zhi
    Huang, Shuo
    Wang, Xiao-kun
    Zhang, Suang
    Wu, Yun
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, 34 (06) : 1039 - 1046
  • [24] T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A Review
    Duong, Benjamin
    Banskota, Pratyush
    Falchook, Gerald S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2024, 7 (02) : 89 - 96
  • [25] Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
    Homayouni, Vida
    Ganjalikhani-hakemi, Mazdak
    Rezaei, Abbas
    Khanahmad, Hossein
    Behdani, Mahdi
    Lomedasht, Fatemeh Kazemi
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 19 (11) : 1201 - 1208
  • [26] Regulation of Th1 T Cell Differentiation by Iron via Upregulation of T Cell Immunoglobulin and Mucin Containing Protein-3 (TIM-3)
    Pfeifhofer-Obermair, Christa
    Tymoszuk, Piotr
    Nairz, Manfred
    Schroll, Andrea
    Klais, Gloria
    Demetz, Egon
    Engl, Sabine
    Brigo, Natascha
    Weiss, Guenter
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Association between T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Genetic Polymorphisms and Susceptibility to Autoimmune Diseases
    Zhang, Rui
    Li, He
    Bai, Linfu
    Duan, Jun
    IMMUNOLOGICAL INVESTIGATIONS, 2019, 48 (06) : 563 - 576
  • [28] The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy
    Cong, Yizi
    Liu, Jing
    Chen, Gang
    Qiao, Guangdong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] T-cell immunoglobulin mucin-3 is underexpressed on myeloblasts in untreated myelodysplastic syndrome
    Garner, Kelly
    Ten Eyck, Stephen
    Craig, Fiona E.
    Roth, Christine G.
    LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 689 - 691
  • [30] Identification of circulating T-cell immunoglobulin and mucin domain 4 as a potential biomarker for coronary heart disease
    Wang, Mengyao
    Gong, Ke
    Zhu, Xinran
    Chen, Shasha
    Zhou, Jie
    Zhang, Hui
    Han, Jihong
    Ma, Likun
    Duan, Yajun
    MEDCOMM, 2023, 4 (04):